POM-V Prescription Required

Loxicom 20 mg/ml Solution for Injection for Cattle, Pigs and Horses

Active ingredient: Meloxicam

Form

Injection

Species

Cattle Horses Pigs

Manufacturer

Norbrook Laboratories Limited

VMD MA No.

02000/5005

What it's used for

Cattle: For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle. For use in diarrhoea in combination...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Loxicom 20 mg/ml Solution for Injection for Cattle, Pigs and Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Cattle:
For use in acute respiratory infection with appropriate antibiotic therapy to reduce
clinical signs in cattle.
For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical
signs in calves of over one week of age and young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with
antibiotic therapy.
For the relief of post-operative pain following dehorning in calves.
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms of lameness
and inflammation.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia
(mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.

Issued: November 2024
AN: 01004/2024
Horses:
For use in the alleviation of inflammation and relief of pain in both acute and chronic
musculo-skeletal disorders.
For the relief of pain associated with equine colic.

Cattle:
Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg
body weight (i.e., 2.5 ml/100 kg body weight) in combination with antibiotic therapy or
with oral re-hydration therapy, as appropriate. The recommended maximum volume
to be administered at a single injection site is 10 ml.
Pigs:
Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e.,
2.0 ml/100 kg body weight) in combination with antibiotic therapy, as appropriate. If
required, a second administration of meloxicam can be given after 24 hours. The
recommended maximum volume to be administered at a single injection site is 2 ml.
Horses:
Single intravenous injection as a dosage of 0.6 mg meloxicam/kg body weight (i.e.,
3.0 ml/100 kg body weight).
For use in the alleviation of inflammation and the relief of pain in both acute and
chronic musculoskeletal disorders, a suitable oral therapy containing meloxicam,

Issued: November 2024
AN: 01004/2024
administered in accordance with label recommendations, may be used for
continuation of treatment.
Avoid introduction of contamination during use.
Do not exceed 50 broachings per vial. If more than 50 broachings are required, the
use of a draw-off needle is recommended.

See also section 4.7.
Do not use in horses less than 6 weeks of age.
Do not use in animals suffering from impaired hepatic, cardiac or renal function and
haemorrhagic disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
For the treatment of diarrhoea in cattle, do not use in animals of less than one week
of age.

In cattle, only a slight transient swelling at the injection site following subcutaneous
administration was observed in less than 10 % of cattle treated in clinical studies.
In horses, a transient swelling at the injection site can occur but resolved without
intervention.
In very rare cases anaphylactoid reactions, which may be serious (including fatal),
may occur and should be treated symptomatically.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reactions)
- common (more than 1 but less than 10 animals treated in 100 animals)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

Treatment of calves with Loxicom 20 minutes before dehorning reduces post-
operative pain. Loxicom alone will not provide adequate pain relief during the
dehorning procedure. To obtain adequate pain relief during surgery co-medication
with an appropriate analgesic is needed.

Special precautions for use in animals
If adverse reactions occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
Avoid use in very severely dehydrated, hypovolaemic or hypotensive animals which
require parenteral rehydration, as there may be a potential risk of renal toxicity.
In cases of inadequate relief of pain when used in the treatment of equine colic,
careful re-evaluation of the diagnosis should be made as this could indicate the need
for surgical intervention.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Accidental self injection may cause pain. People with known hypersensitivity to Non-
Steroidal Anti-Inflammatory Drugs (NSAIDs) should avoid contact with the veterinary
medicinal product.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
This product can cause eye irritation. In case of contact with the eyes, immediately
rinse thoroughly with water.

Issued: November 2024
AN: 01004/2024

Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-
inflammatory drugs or with anti-coagulant agents.

This veterinary medicinal product does not require any special storage conditions.

Issued: November 2024
AN: 01004/2024

Cattle:
Pigs:
Horses:
Not authorised for use in horses producing milk for human consumption.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.